A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by

Kerstin Hünniger1, Kristin Bieber1, Ronny Martin1

  • 1Septomics Research Center, Friedrich Schiller University and Leibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute, 07745 Jena, Germany;

Insights

The anaphylatoxin C5a is crucial for polymorphonuclear neutrophilic granulocytes (PMN) to effectively combat Candida albicans infections in human blood, enhancing early immune responses.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Polymorphonuclear neutrophilic granulocytes (PMN) are key innate immune cells fighting systemic Candida albicans infections.
  • Understanding PMN activation during infection is vital for developing effective treatments.

Purpose of the Study:

  • To investigate the stimuli required for PMN activation during Candida albicans infection in a human whole-blood model.
  • To elucidate the role of anaphylatoxin C5a in early anti-Candida immune responses.

Main Methods:

  • Utilized a human whole-blood infection model with Candida albicans.
  • Analyzed PMN activation, oxidative burst, granule release, and phagocytosis.
  • Investigated the effects of blocking C5a receptor signaling and using a humanized anti-C5a antibody.
  • Assessed CD11b surface expression on PMN.

Main Results:

  • PMN activation at 10 minutes post-Candida albicans infection was highly dependent on C5a.
  • C5a facilitated PMN recognition and elimination of nonfilamentous C. albicans.
  • Blocking C5a signaling or using anti-C5a antibodies inhibited major PMN effector functions.
  • C5a-dependent CD11b expression mediated early C. albicans phagocytosis.
  • Later phagocytosis (60 minutes) was largely C5a-independent.

Conclusions:

  • C5a is a critical mediator of early innate immune responses against Candida albicans in human blood.
  • The C5a-C5aR-CD11b axis significantly modulates early anti-Candida immunity.
  • Targeting C5a may offer therapeutic potential for systemic Candida infections.